Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.7800
-0.0487 (-5.88%)
At close: Mar 13, 2026, 4:00 PM EDT
0.7854
+0.0054 (0.69%)
After-hours: Mar 13, 2026, 7:51 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $1.17 million as of March 13, 2026. Its market cap has decreased by -78.12% in one year.
Market Cap
1.17M
Enterprise Value
-9.17M
1-Year Change
-78.12%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.16M to $1.17M, a decrease of -95.53%. That is a compound annual growth rate of -49.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.40M | -48.43% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.12% |
| Dec 30, 2022 | 7.82M | -59.15% |
| Dec 27, 2021 | 19.13M | -26.88% |
| Aug 16, 2021 | 26.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scinai Immunotherapeutics | 2.53M |
| Jaguar Health | 2.48M |
| Calidi Biotherapeutics | 2.44M |
| PMGC Holdings | 2.38M |
| Lyra Therapeutics | 2.38M |
| Bone Biologics | 2.26M |
| Propanc Biopharma | 1.92M |
| CNS Pharmaceuticals | 1.76M |